The animal’s body produces enzymes to break down fats, carbohydrates, and proteins obtained from food. In cases of pancreatic disease, the amount of produced enzymes decreases (enzymatic insufficiency), and it becomes necessary to compensate for the missing enzymes.

Dolfos AmylaDol contains natural enzymes: lipase, amylase, and protease. The amount of lipase in a tablet significantly exceeds the amount of amylase and protease — this is because in pancreatic diseases, the level of lipase decreases much faster than amylase and protease.

Dolfos AmylaDol is recommended for digestive disorders in cats and dogs related to chronic pancreatic insufficiency.

Features and Benefits:

• contains amylase — an enzyme that breaks down starch into oligosaccharides;
• lipase — an enzyme that, together with bile in the stomach, breaks down fats, fatty acids, and fat-soluble vitamins A, D, E, K, converting them into energy and heat;
• protease — a pancreatic enzyme that breaks peptide bonds between amino acids in proteins;
• ensures effective digestion of fats, proteins, and carbohydrates;
• recommended for cats that suffer from or are prone to pancreatitis;
• for digestive disorders;
• as monotherapy for maldigestion syndrome (nausea, diarrhea, flatulence, burping, abdominal discomfort).

Composition:

Brewer’s yeast, maltodextrin.

Each tablet contains:

• Amylase — 13,400 Ph.Eur.u
• Lipase — 9,200 Ph.Eur.u
• Protease — 960 Ph.Eur.u

Analytical Constituents:

• Crude protein — 0.5%
• Crude fiber — 0.2%
• Crude ash — 35.4%
• Oil and crude fat — 0%

Dosage and Administration:

• Cats and small dog breeds — 1 tablet per day
• Medium-sized dogs — 2 tablets per day
• Large dogs — 3 tablets per day

The tablet should be administered in the morning before feeding. The recommended duration of use is 3 to 12 weeks. However, in cases of chronic pancreatic insufficiency, the product is prescribed for lifelong use.

Manufacturer: Dolfos, Dolfos Sp. z o.o. Sp. k., Poland